This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Enzo Biochem, Inc.

Drug Names(s): EHT899

Description: EHT899 is a proprietary oral formulation of an HBV viral protein designed to eliminate the undesirable immune response elicited by the HBV infection. It may also enhance a secondary immune response to clear the viral infection, resulting in reduction in liver damage and decrease in viral load.

EHT899 News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug